| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biological Sciences, University of California, Santa Barbara, California 93106
We have used a structure-activity approach to investigate whether the Vinca alkaloids inhibit cell proliferation primarily by means of their effects on mitotic spindle microtubules or by another mechanism or by a combination of mechanisms. Five Vinca alkaloids were used to investigate the relationship in HeLa cells between inhibition of cell proliferation and blockage of mitosis, alteration of spindle organization, and depolymerization of microtubules. Indirect immunofluorescence staining of microtubules and 4,6-diamidino-2-phenylindole staining of chromatin were used to characterize the effects of the drugs on the distributions of cells in stages of the cell cycle and on the organization of microtubules and chromosomes in metaphase spindles. The microtubule polymer was isolated from cells and quantified using a competitive enzyme-linked immunoadsorbent assay for tubulin. We observed a nearly perfect coincidence between the concentration of each Vinca derivative that inhibited cell proliferation and the concentration that caused 50% accumulation of cells at metaphase, despite the fact that the antiproliferative potencies of the drugs varied over a broad concentration range. Inhibition of cell proliferation and blockage of cells at metaphase at the lowest effective concentrations of all Vinca derivatives occurred with little or no microtubule depolymerization or spindle disorganization. With increasing drug concentrations, the organization of microtubules and chromosomes in arrested mitotic spindles deteriorated in a manner that was common to all five congeners. These results indicate that the antiproliferative activity of the Vinca alkaloids at their lowest effective concentrations in HeLa cells is due to inhibition of mitotic spindle function. The results suggest further that the Vinca alkaloids inhibit cell proliferation by altering the dynamics of tubulin addition and loss at the ends of mitotic spindle microtubules rather than by depolymerizing the microtubules. The specific alterations of spindle microtubule dynamics appear to differ among the five Vinca congeners, and such differences may be responsible for differences in the antitumor specificities of the drugs.
1 Supported by Grant CH-381 from the American Cancer Society, and a Grant-In-Aid from The Eli Lilly Research Laboratories. Preliminary reports describing portions of this work have appeared elsewhere (Jordan, M. A., Thrower, D., and Wilson, L., J. Cell Biol., 107: 237a, 1988, and J. Cell Biol., 109: 89a, 1989.
2 To whom requests for reprints should be addressed.
Received 10/ 1/90. Accepted 2/ 1/91.
This article has been cited by other articles:
|
|
 |
|
  K. E. Gascoigne and S. S. Taylor How do anti-mitotic drugs kill cancer cells? J. Cell Sci., August 1, 2009; 122(15): 2579 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Drummond, C. O. Noble, Z. Guo, M. E. Hayes, J. W. Park, C.-J. Ou, Y.-L. Tseng, K. Hong, and D. B. Kirpotin Improved Pharmacokinetics and Efficacy of a Highly Stable Nanoliposomal Vinorelbine J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 321 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Wang, L.-X. Hu, Z.-M. Liu, X.-F. You, S.-H. Zhang, J.-R. Qu, Z.-R. Li, Y. Li, W.-J. Kong, H.-W. He, et al. N-(2,6-Dimethoxypyridine-3-yl)-9-Methylcarbazole-3-Sulfonamide as a Novel Tubulin Ligand against Human Cancer Clin. Cancer Res., October 1, 2008; 14(19): 6218 - 6227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Brito, Z. Yang, and C. L. Rieder Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied J. Cell Biol., August 25, 2008; 182(4): 623 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Liberatore, H. Coulomb, D. Pons, O. Dutruel, P. G. Kasprzyk, M. Carlson, A. S. Nelson, S. P. Newman, C. Stengel, P. Auvray, et al. IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents Mol. Cancer Ther., August 1, 2008; 7(8): 2426 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okouneva, O. Azarenko, L. Wilson, B. A. Littlefield, and M. A. Jordan Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase Mol. Cancer Ther., July 1, 2008; 7(7): 2003 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Teicher Newer Cytotoxic Agents: Attacking Cancer Broadly Clin. Cancer Res., March 15, 2008; 14(6): 1610 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Munoz-Fontela, L. Marcos-Villar, F. Hernandez, P. Gallego, E. Rodriguez, J. Arroyo, S.-J. Gao, J. Avila, and C. Rivas Induction of Paclitaxel Resistance by the Kaposi's Sarcoma-Associated Herpesvirus Latent Protein LANA2 J. Virol., February 1, 2008; 82(3): 1518 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Azambuja, V. Durbecq, D. D. Rosa, M. Colozza, D. Larsimont, M. Piccart-Gebhart, and F. Cardoso HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer Ann. Onc., February 1, 2008; 19(2): 223 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Park, S. E. Aiyar, P. Fan, J. Wang, W. Yue, T. Okouneva, C. Cox, M. A. Jordan, L. Demers, H. Cho, et al. Effects of Tetramethoxystilbene on Hormone-Resistant Breast Cancer Cells: Biological and Biochemical Mechanisms of Action Cancer Res., June 15, 2007; 67(12): 5717 - 5726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Groth-Pedersen, M. S. Ostenfeld, M. Hoyer-Hansen, J. Nylandsted, and M. Jaattela Vincristine Induces Dramatic Lysosomal Changes and Sensitizes Cancer Cells to Lysosome-Destabilizing Siramesine Cancer Res., March 1, 2007; 67(5): 2217 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. H. Young, F. M. Rubio, and P. O. Danis A Radioligand Binding Assay for Antitubulin Activity in Tumor Cells J Biomol Screen, February 1, 2006; 11(1): 82 - 89. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Kai, M. Yoshida, T. Sugawara, M. Kato, K. Uchida, R. Yamaguchi, S. Tateyama, and K. Furuhuma Investigation of Initial Changes in the Mouse Olfactory Epithelium Following a Single Intravenous Injection of Vincristine Sulphate Toxicol Pathol, December 1, 2005; 33(7): 752 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-K. Huang, J. M. Bailis, J. D. Leverson, E. B. Gomez, S. L. Forsburg, and T. Hunter Suppressors of Bir1p (Survivin) Identify Roles for the Chromosomal Passenger Protein Pic1p (INCENP) and the Replication Initiation Factor Psf2p in Chromosome Segregation Mol. Cell. Biol., October 15, 2005; 25(20): 9000 - 9015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Jordan, K. Kamath, T. Manna, T. Okouneva, H. P. Miller, C. Davis, B. A. Littlefield, and L. Wilson The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth Mol. Cancer Ther., July 1, 2005; 4(7): 1086 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Mussali-Galante, M. Avila-Costa, G Pinon-Zarate, G Martinez-Levy, V Rodriguez-Lara, M Rojas-Lemus, M. Avila-Casado, and T. Fortoul DNA damage as an early biomarker of effect in human health Toxicology and Industrial Health, June 1, 2005; 21(5-6): 155 - 166. [Abstract] [PDF]
|
|
|
|
|
|
J. Pyka, A. Glogowska, H. Dralle, C. Hoang-Vu, and T. Klonisch Cytoplasmic Domain of proEGF Affects Distribution and Post-Translational Modification of Microtubuli and Increases Microtubule-Associated Proteins 1b and 2 Production in Human Thyroid Carcinoma Cells Cancer Res., February 15, 2005; 65(4): 1343 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Pourroy, M. Carre, S. Honore, V. Bourgarel-Rey, A. Kruczynski, C. Briand, and D. Braguer Low Concentrations of Vinflunine Induce Apoptosis in Human SK-N-SH Neuroblastoma Cells through a Postmitotic G1 Arrest and a Mitochondrial Pathway Mol. Pharmacol., September 1, 2004; 66(3): 580 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Theis, A. Knorre, B. Kellersch, J. Moelleken, F. Wieland, W. Kolanus, and M. Famulok Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2 PNAS, August 3, 2004; 101(31): 11221 - 11226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Stathopoulos, M. Veslemes, N. Georgatou, D. Antoniou, P. Giamboudakis, K. Katis, D. Tsavdaridis, S. K. Rigatos, I. Dimitroulis, S. Bastani, et al. Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial Ann. Onc., July 1, 2004; 15(7): 1048 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Honore, K. Kamath, D. Braguer, L. Wilson, C. Briand, and M. A. Jordan Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation Mol. Cancer Ther., December 1, 2003; 2(12): 1303 - 1311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cemazar, M. Auersperg, J. Scancar, I. S. Kirbis, A. Pogacnik, and G. Sersa Schedule-Dependent Interaction between Vinblastine and Cisplatin in Ehrlich Ascites Tumors in Mice J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 337 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Motlagh, K. J Alden, B. Russell, and J. Garcia Sodium current modulation by a tubulin/GTP coupled process in rat neonatal cardiac myocytes J. Physiol., April 1, 2002; 540(1): 93 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Taylor, D. Hussein, Y. Wang, S. Elderkin, and C. J. Morrow Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells J. Cell Sci., March 14, 2002; 114(24): 4385 - 4395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. He, C.-P. Huang Yang, and S. B. Horwitz Mutations in {beta}-Tubulin Map to Domains Involved in Regulation of Microtubule Stability in Epothilone- resistant Cell Lines Mol. Cancer Ther., November 1, 2001; 1(1): 3 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. K. Ngan, K. Bellman, B. T. Hill, L. Wilson, and M. A. Jordan Mechanism of Mitotic Block and Inhibition of Cell Proliferation by the Semisynthetic Vinca Alkaloids Vinorelbine and Its Newer Derivative Vinflunine Mol. Pharmacol., July 1, 2001; 60(1): 225 - 232. [Abstract] [Full Text]
|
|
|
|
|
|
G. Sersa, M. Krzic, M. Sentjurc, T. Ivanusa, K. Beravs, M. Cemazar, M. Auersperg, and H. M. Swartz Reduced Tumor Oxygenation by Treatment with Vinblastine Cancer Res., May 1, 2001; 61(10): 4266 - 4271. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Towle, K. A. Salvato, J. Budrow, B. F. Wels, G. Kuznetsov, K. K. Aalfs, S. Welsh, W. Zheng, B. M. Seletsky, M. H. Palme, et al. In Vitro and In Vivo Anticancer Activities of Synthetic Macrocyclic Ketone Analogues of Halichondrin B Cancer Res., February 1, 2001; 61(3): 1013 - 1021. [Abstract] [Full Text]
|
|
|
|
|
|
T. A. Stadheim, H. Xiao, and A. Eastman Inhibition of Extracellular Signal-regulated Kinase (ERK) Mediates Cell Cycle Phase Independent Apoptosis in Vinblastine-treated ML-1 Cells Cancer Res., February 1, 2001; 61(4): 1533 - 1540. [Abstract] [Full Text]
|
|
|
|
|
|
C Iancu, S. Mistry, S Arkin, S Wallenstein, and G. Atweh Effects of stathmin inhibition on the mitotic spindle J. Cell Sci., January 3, 2001; 114(5): 909 - 916. [Abstract] [PDF]
|
|
|
|
|
|
G. Bacher, B. Nickel, P. Emig, U. Vanhoefer, S. Seeber, A. Shandra, T. Klenner, and T. Beckers D-24851, a Novel Synthetic Microtubule Inhibitor, Exerts Curative Antitumoral Activity in Vivo, Shows Efficacy toward Multidrug-resistant Tumor Cells, and Lacks Neurotoxicity Cancer Res., January 1, 2001; 61(1): 392 - 399. [Abstract] [Full Text]
|
|
|
|
|
|
M. Fan, L. Du, A. A. Stone, K. M. Gilbert, and T. C. Chambers Modulation of Mitogen-activated Protein Kinases and Phosphorylation of Bcl-2 by Vinblastine Represent Persistent Forms of Normal Fluctuations at G2-M Cancer Res., November 1, 2000; 60(22): 6403 - 6407. [Abstract] [Full Text]
|
|
|
|
|
|
V. K. Ngan, K. Bellman, D. Panda, B. T. Hill, M. A. Jordan, and L. Wilson Novel Actions of the Antitumor Drugs Vinflunine and Vinorelbine on Microtubules Cancer Res., September 1, 2000; 60(18): 5045 - 5051. [Abstract] [Full Text]
|
|
|
|
|
|
H.-J. Kuh, S. H. Jang, M. G. Wientjes, and J. L.-S. Au Computational Model of Intracellular Pharmacokinetics of Paclitaxel J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 761 - 770. [Abstract] [Full Text]
|
|
|
|
|
|
P. Verdier-Pinard, J. A. Kepler, G. R. Pettit, and E. Hamel Sustained Intracellular Retention of Dolastatin 10 Causes Its Potent Antimitotic Activity Mol. Pharmacol., January 1, 2000; 57(1): 180 - 187. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. O'Brien, B. Vulevic, S. Freer, J. Boyd, H. Shen, and K. D. Tew Glutathione Peptidomimetic Drug Modulator of Multidrug Resistance-Associated Protein J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1348 - 1355. [Abstract] [Full Text]
|
|
|
|
|
|
S. Lobert, J. W. Ingram, and J. J. Correia Additivity of Dilantin and Vinblastine Inhibitory Effects on Microtubule Assembly Cancer Res., October 1, 1999; 59(19): 4816 - 4822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dumontet and B. I. Sikic Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death J. Clin. Oncol., March 1, 1999; 17(3): 1061 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Panda, K. DeLuca, D. Williams, M. A. Jordan, and L. Wilson Antiproliferative mechanism of action of cryptophycin-52: Kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends PNAS, August 4, 1998; 95(16): 9313 - 9318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lobert, J. W. Ingram, B. T. Hill, and J. J. Correia A Comparison of Thermodynamic Parameters for Vinorelbine- and Vinflunine-Induced Tubulin Self-Association by Sedimentation Velocity Mol. Pharmacol., May 1, 1998; 53(5): 908 - 915. [Abstract] [Full Text]
|
|
|
|
|
|
D. Panda, H. P. Miller, K. Islam, and L. Wilson Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: A possible mechanistic basis for its antitumor action PNAS, September 30, 1997; 94(20): 10560 - 10564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lanni, S. W. Lowe, E. J. Licitra, J. O. Liu, and T. Jacks p53-independent apoptosis induced by paclitaxel through an indirect mechanism PNAS, September 2, 1997; 94(18): 9679 - 9683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Challacombe, D. M. Snow, and P. C. Letourneau Dynamic Microtubule Ends Are Required for Growth Cone Turning to Avoid an Inhibitory Guidance Cue J. Neurosci., May 1, 1997; 17(9): 3085 - 3095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Panda, J. P. Singh, and L. Wilson Suppression of Microtubule Dynamics by LY290181. A POTENTIAL MECHANISM FOR ITS ANTIPROLIFERATIVE ACTION J. Biol. Chem., March 21, 1997; 272(12): 7681 - 7687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Sluder, E. Thompson, F. Miller, J Hayes, and C. Rieder The checkpoint control for anaphase onset does not monitor excess numbers of spindle poles or bipolar spindle symmetry J. Cell Sci., January 2, 1997; 110(4): 421 - 429. [Abstract] [PDF]
|
|
|
|
|
|
D. Panda, M. A. Jordan, K. C. Chu, and L. Wilson Differential Effects of Vinblastine on Polymerization and Dynamics at Opposite Microtubule Ends J. Biol. Chem., November 22, 1996; 271(47): 29807 - 29812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Smith and X. Zhang Mechanism of Action of Cryptophycin J. Biol. Chem., March 15, 1996; 271(11): 6192 - 6198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmad and P. Baas Microtubules released from the neuronal centrosome are transported into the axon J. Cell Sci., January 8, 1995; 108(8): 2761 - 2769. [Abstract] [PDF]
|
|
|
|
|
|
K. Wendell, L Wilson, and M. Jordan Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes J. Cell Sci., January 2, 1993; 104(2): 261 - 274. [Abstract] [PDF]
|
|
|
|
|
|
N. C. Crespo, J. Ohkanda, T. J. Yen, A. D. Hamilton, and S. M. Sebti The Farnesyltransferase Inhibitor, FTI-2153, Blocks Bipolar Spindle Formation and Chromosome Alignment and Causes Prometaphase Accumulation during Mitosis of Human Lung Cancer Cells J. Biol. Chem., May 4, 2001; 276(19): 16161 - 16167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. DeLuca, C. N. Newton, R. H. Himes, M. A. Jordan, and L. Wilson Purification and Characterization of Native Conventional Kinesin, HSET, and CENP-E from Mitotic HeLa Cells J. Biol. Chem., July 20, 2001; 276(30): 28014 - 28021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Skoufias, P. R. Andreassen, F. B. Lacroix, L. Wilson, and R. L. Margolis Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints PNAS, April 10, 2001; 98(8): 4492 - 4497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Motlagh, K. J Alden, B. Russell, and J. Garcia Sodium current modulation by a tubulin/GTP coupled process in rat neonatal cardiac myocytes J. Physiol., April 1, 2002; 540(1): 93 - 103. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
